Aug 31 (Reuters) - Theratechnologies Inc TH.TO :
* Announces commercialization agreement for tesamorelin in South Korea
* Says agreement has a 10-year term
* Says bl&h intends to distribute egrifta in the territory through named
patient sales programs
* Bl&h will be responsible to conduct all regulatory activities required to
obtain marketing approval for egrifta in South Korea
* Says will manufacture and supply Egrifta(TM) to bl&h at a predetermined
transfer price
* Source text for Eikon ID:nMKWMGpmha
* Further company coverage TH.TO